Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-01-17 to 2024-02-07
Current total value of award: $192663.9
Description: 4563373062!OCREVUS 300 MG/10 ML VIAL 10ML